Kainos Laboratories

Kainos Laboratories Interest Coverage

Delisted

The Interest Coverage Ratio of Kainos Laboratories (4556.T) as of Oct 29, 2026 is 193.24. In the previous year, Interest Coverage Ratio was 191.89 — a change of 0.71% (higher).

Interest Coverage

193.24

YoY

0.71%

Last updated:

Interest Coverage Ratio of Kainos Laboratories is 2025 193.24 . Interest Coverage Ratio of Kainos Laboratories was 2024 191.89 . It decreases by 0.71% higher compared to the previous year.

The Kainos Laboratories Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
27.47 JPY
Jan 1, 2019
119.67 JPY
Jan 1, 2020
272.89 JPY
Jan 1, 2021
135.77 JPY
Jan 1, 2022
58.77 JPY
Jan 1, 2023
72.90 JPY
Jan 1, 2024
191.89 JPY
Jan 1, 2025
193.24 JPY
The Kainos Laboratories Interest Coverage history
YEARInterest CoverageYoY
193.24+0.71%
191.89+163.24%
72.90+24.03%
58.77-56.71%
135.77-50.25%
272.89+128.03%
119.67+335.65%
27.47-33.23%
41.14-56.47%
94.51+142.78%
38.93+73.66%
22.42—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kainos Laboratories Stock analysis

What does Kainos Laboratories do? Kainos Laboratories Inc develops and manufactures pharmaceuticals, diagnostic reagents, and related chemical products for distribution and import/export. The company sells its products to healthcare providers, hospitals, and medical institutions within Japan and internationally. Its core offerings include prescription medications, diagnostic tools, and chemical compounds used in medical research and treatment. The business model relies on direct sales to medical facilities and global trade of its pharmaceutical and diagnostic solutions. Kainos Laboratories Inc focuses on the Japanese market with its headquarters in Bunkyo-Ku, Tokyo-To, while also engaging in international import/export activities. The company's revenue streams come from the sale of pharmaceuticals, diagnostic reagents, and chemical products to healthcare professionals and institutions. Its product portfolio targets medical practitioners and research organizations requiring specialized diagnostic and therapeutic solutions. The company operates with 144 full-time employees dedicated to the development, manufacturing, and distribution of its products. Kainos Laboratories Inc generates income through the commercialization of its pharmaceuticals and diagnostic reagents, serving both domestic and global clients in the healthcare sector. Sales are driven by demand for medical treatments and diagnostic tools in clinical and research settings. Kainos Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kainos Laboratories stock

Interest Coverage Ratio of Kainos Laboratories is 193.24 in 2025.

Interest Coverage Ratio of Kainos Laboratories changed from 191.89 to 193.24, representing a 0.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Kainos Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Kainos Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Kainos Laboratories

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Kainos Laboratories